WO2026059524 - A CAPSULE FORMULATION COMPRISING CARIPRAZINE HYDROCHLORIDE
National phase entry is expected:
Publication Number
WO/2026/059524
Publication Date
19.03.2026
International Application No.
PCT/TR2025/051102
International Filing Date
08.09.2025
Title **
[English]
A CAPSULE FORMULATION COMPRISING CARIPRAZINE HYDROCHLORIDE
[French]
FORMULATION EN CAPSULE COMPRENANT DU CHLORHYDRATE DE CARIPRAZINE
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
PEHLIVAN AKALIN, Nur
ARMUT, Merve
OZTAS, Bora
Priority Data
2024/011969
10.09.2024
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1958 | |
| EPO | Filing, Examination, Granting | 9151 | |
| Japan | Filing, Examination, Granting | 2000 | |
| South Korea | Filing, Examination, Granting | 1802 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,651
Contact Us
Abstract[English]
The present invention relates to a capsule formulation comprising cariprazine hydrochloride and at least one filler, wherein the filler is sodium starch glycolate and its amount is between 85.0% and 99.0% in the total formulation. The present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient method of preparing the formulation.[French]
La présente invention concerne une formulation en capsule comprenant du chlorhydrate de cariprazine et au moins une charge, la charge étant du glycolate d'amidon sodique et sa quantité étant comprise entre 85,0 % et 99,0 % dans la formulation totale. La présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement pratique pour la préparation de la formulation.